Baxter to Present at Raymond James 34th Annual Institutional Investors Conference

Before you go, we thought you'd like these...
Before you go close icon

Baxter to Present atRaymond James 34thAnnual Institutional Investors Conference

DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International Inc. (NYS: BAX) announced today that it will present at the Raymond James 34th Annual Institutional Investors Conference on Tuesday, March 5, 2013 at 7:05 a.m. (CT).

The live webcast of Baxter's presentation along with the slides can be accessed from the Baxter corporate website at www.baxter.com and will be available for replay through April 4, 2013.


Baxter International Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.



Baxter International Inc.
Media Contacts
Deborah Spak, (224) 948-2349
or
Investor Contacts
Mary Kay Ladone, (224) 948-3371
Clare Trachtman, (224) 948-3085

KEYWORDS:   United States  North America  Illinois

INDUSTRY KEYWORDS:

The article Baxter to Present at Raymond James 34th Annual Institutional Investors Conference originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Want more news like this?

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

From Our Partners